Click on a filter below to refine your search. Remove a filter to broaden your search.
Compared with those without COVID-19, similar deficits were seen for those in whom symptoms resolved in less than four or at least 12 weeks.
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
A high false-positive rate was seen when used in primary care with a diverse patient population.
Exogenous thyrotoxicosis remained a significant risk factor for cognitive disorders when stratified by cause and severity.
Associations with accelerated cognitive decline and increased dementia risk were seen for white participants and those aged fewer than 65 years.
Only 0.1% of clinicians and practices have diagnosis rates within the expected range.
A combination of lower neighborhood income and lower greenspace may be a risk factor for worsening white matter grade on MRI.
Cognitively enhanced tai ji quan therapy was superior to standard tai ji quan and stretching exercise for improving global cognition.